Northern Trust’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-366,059
Closed -$13.8M 4680
2021
Q1
$13.8M Sell
366,059
-21,197
-5% -$799K ﹤0.01% 2078
2020
Q4
$6.59M Buy
387,256
+35,080
+10% +$597K ﹤0.01% 2509
2020
Q3
$1.66M Sell
352,176
-10,480
-3% -$49.3K ﹤0.01% 3143
2020
Q2
$2.21M Sell
362,656
-63,994
-15% -$390K ﹤0.01% 2992
2020
Q1
$969K Buy
426,650
+31,273
+8% +$71K ﹤0.01% 3236
2019
Q4
$1.82M Sell
395,377
-30,652
-7% -$141K ﹤0.01% 3186
2019
Q3
$1.65M Sell
426,029
-17,162
-4% -$66.5K ﹤0.01% 3210
2019
Q2
$2.67M Buy
443,191
+12,054
+3% +$72.7K ﹤0.01% 2906
2019
Q1
$5.78M Buy
431,137
+5,362
+1% +$71.8K ﹤0.01% 2477
2018
Q4
$3.96M Buy
425,775
+2,278
+0.5% +$21.2K ﹤0.01% 2646
2018
Q3
$5.9M Buy
423,497
+28,619
+7% +$398K ﹤0.01% 2598
2018
Q2
$6.24M Buy
394,878
+24,838
+7% +$393K ﹤0.01% 2565
2018
Q1
$6.36M Buy
370,040
+46,742
+14% +$803K ﹤0.01% 2443
2017
Q4
$7.09M Buy
323,298
+1,014
+0.3% +$22.2K ﹤0.01% 2399
2017
Q3
$13.2M Sell
322,284
-13,204
-4% -$540K ﹤0.01% 2017
2017
Q2
$10.1M Buy
335,488
+3,770
+1% +$114K ﹤0.01% 2180
2017
Q1
$12M Buy
331,718
+1,262
+0.4% +$45.6K ﹤0.01% 1989
2016
Q4
$16.6M Sell
330,456
-7,287
-2% -$365K 0.01% 1737
2016
Q3
$17.7M Buy
337,743
+12,809
+4% +$672K 0.01% 1683
2016
Q2
$13.4M Buy
324,934
+24,941
+8% +$1.03M ﹤0.01% 1817
2016
Q1
$11.4M Buy
299,993
+2,813
+0.9% +$107K ﹤0.01% 1877
2015
Q4
$12.3M Buy
297,180
+25,234
+9% +$1.05M ﹤0.01% 1854
2015
Q3
$4.19M Buy
271,946
+37,018
+16% +$570K ﹤0.01% 2552
2015
Q2
$5.84M Buy
234,928
+18,120
+8% +$450K ﹤0.01% 2427
2015
Q1
$4.95M Buy
216,808
+51,393
+31% +$1.17M ﹤0.01% 2510
2014
Q4
$4.47M Sell
165,415
-1,757
-1% -$47.4K ﹤0.01% 2582
2014
Q3
$1.96M Buy
167,172
+78,896
+89% +$925K ﹤0.01% 3116
2014
Q2
$1.37M Buy
88,276
+14,436
+20% +$225K ﹤0.01% 3274
2014
Q1
$1.45M Sell
73,840
-3,327
-4% -$65.5K ﹤0.01% 3278
2013
Q4
$1.3M Buy
+77,167
New +$1.3M ﹤0.01% 3319